Indications:

This product has been shown to be effective for the vaccination of healthy dogs, cats and ferrets 12 weeks of age or older against rabies. Duration of immunity of at least 1 year has been demonstrated in ferrets, and at least 3 years in dogs and cats after repeat dose. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

EFFICACY & COMPARISONS

Rabies Challenge Studies

• Duration of immunity studies demonstrated that a 1 mL dose met federal guidelines for protection of dogs and cats against virulent challenge administered 3 years after vaccination and ferrets when challenged 1 year after vaccination.

NOBIVAC^® 3-RABIES VACCINE IS A SAFE CHOICE

• Proven to be uniformly safe in experimental tests, with no significant adverse reactions in extensive clinical trials.¹

ADMINISTRATION AND DOSAGE

• Subcutaneous 1 mL injection for cats
• Subcutaneous or intramuscular 1 mL injection for dogs
• Administer a single dose at 12 weeks of age or older in healthy cats and dogs; repeat dose should be administered 1 year later
• Subcutaneous 1 mL injection for ferrets, repeat dose should be administered 1 year later. Annual revaccination with 1 dose is recommended.
• Available in two presentations: 50 x 1 mL, and 5 x 10 mL vials

ALSO AVAILABLE IN OTHER FORMULATIONS

• NOBIVAC^® 1-RABIES
• NOBIVAC^® 3-RABIES CA

DISEASE INFORMATION

• Feline Rabies
• Canine Rabies